tetradecanoylphorbol acetate and fidaxomicin

tetradecanoylphorbol acetate has been researched along with fidaxomicin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Kelly, CP; Koon, HW; Lee, EC; Mussatto, CC; Ortiz, C; Pothoulakis, C; Tran, DH; Wang, J	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and fidaxomicin

Article	Year
Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1 Topics: Aminoglycosides; Animals; Apoptosis; Bacterial Proteins; Bacterial Toxins; Cell Line; Clostridioides difficile; Enterotoxins; Epithelial Cells; Fidaxomicin; Humans; Inflammation; Interleukin-1beta; Intestinal Mucosa; Mice; NF-kappa B; Phosphorylation; RAW 264.7 Cells; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha	2018

Article

Year

Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.

Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1

Topics: Aminoglycosides; Animals; Apoptosis; Bacterial Proteins; Bacterial Toxins; Cell Line; Clostridioides difficile; Enterotoxins; Epithelial Cells; Fidaxomicin; Humans; Inflammation; Interleukin-1beta; Intestinal Mucosa; Mice; NF-kappa B; Phosphorylation; RAW 264.7 Cells; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2018